Cancer Incidence and Mortality among Non-Hispanic White Individuals, New York City, 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 17,694.0 490.7 487.3-494.0 8,612.4 510.0 505.1-514.9 9,081.6 485.0 480.3-489.8 4,920.8 123.1 121.5-124.7 2,406.8 138.8 136.2-141.3 2,514.0 112.5 110.4-114.6
Oral cavity and pharynx 396.0 10.9 10.4-11.4 263.0 15.6 14.7-16.5 133.0 6.8 6.2-7.3 77.0 2.0 1.8-2.2 51.8 3.0 2.7-3.4 25.2 1.1 0.9-1.4
Esophagus 140.0 3.6 3.4-3.9 101.2 5.8 5.3-6.4 38.8 1.8 1.5-2.0 95.8 2.5 2.2-2.7 73.2 4.2 3.8-4.7 22.6 1.0 0.8-1.2
Stomach 271.6 7.4 7.0-7.8 154.2 9.2 8.6-9.9 117.4 5.9 5.4-6.4 123.0 3.2 2.9-3.4 75.0 4.4 4.0-4.9 48.0 2.2 1.9-2.5
Colorectal 1,374.4 37.7 36.8-38.6 719.2 43.4 41.9-44.8 655.2 32.8 31.6-34.0 455.4 11.3 10.9-11.8 230.2 13.3 12.6-14.2 225.2 9.7 9.2-10.4
Colon excluding rectum 986.0 26.5 25.7-27.3 503.4 30.1 28.9-31.3 482.6 23.4 22.4-24.4 367.8 9.0 8.6-9.5 183.2 10.5 9.8-11.2 184.6 7.9 7.4-8.5
Rectum & rectosigmoid 388.4 11.2 10.7-11.7 215.8 13.2 12.4-14.1 172.6 9.4 8.7-10.1 87.6 2.3 2.1-2.6 47.0 2.9 2.5-3.3 40.6 1.8 1.6-2.1
Liver / intrahepatic bile duct 287.2 7.5 7.1-7.9 202.6 11.6 10.9-12.4 84.6 4.0 3.6-4.4 179.8 4.6 4.3-4.9 115.6 6.6 6.1-7.2 64.2 2.8 2.5-3.2
Pancreas 565.2 14.4 13.9-15.0 280.4 16.3 15.4-17.2 284.8 12.8 12.1-13.5 434.2 10.7 10.3-11.2 215.8 12.4 11.7-13.2 218.4 9.3 8.7-9.9
Larynx 93.8 2.5 2.3-2.8 77.0 4.5 4.1-5.0 16.8 0.9 0.7-1.1 27.0 0.7 0.6-0.8 22.0 1.3 1.0-1.5 5.0 0.2 0.1-0.3
Lung and bronchus 1,988.2 51.2 50.1-52.2 937.8 54.3 52.7-55.9 1,050.4 49.0 47.6-50.4 1,007.4 25.0 24.3-25.7 506.4 29.1 27.9-30.2 501.0 21.9 21.0-22.8
Melanoma of the skin 789.6 22.2 21.5-23.0 446.8 27.0 25.9-28.2 342.8 18.7 17.8-19.7 66.0 1.7 1.5-1.9 38.8 2.3 2.0-2.7 27.2 1.3 1.1-1.5
Female breast             2,666.8 152.5 149.8-155.3             398.2 18.6 17.8-19.5
Cervix uteri             105.4 6.8 6.2-7.4             24.6 1.4 1.2-1.7
Corpus uterus and NOS             619.0 32.9 31.7-34.1             121.2 5.6 5.1-6.0
Ovary             228.2 12.6 11.8-13.4             147.2 7.0 6.5-7.6
Prostate       2,012.0 113.4 111.2-115.7             236.8 13.2 12.5-14.0      
Testis       128.8 9.1 8.4-9.8             2.0 0.1 0.1-0.3      
Urinary bladder (incl. in situ) 938.2 24.0 23.3-24.7 704.0 40.7 39.4-42.1 234.2 10.9 10.2-11.5 167.4 3.8 3.6-4.1 117.6 6.5 6.0-7.1 49.8 1.9 1.7-2.2
Kidney and renal pelvis 601.6 17.2 16.6-17.8 407.2 24.8 23.7-25.9 194.4 10.5 9.8-11.2 98.2 2.5 2.2-2.7 65.6 3.8 3.4-4.2 32.6 1.4 1.2-1.7
Brain and other central nervous system 247.8 7.9 7.4-8.4 137.6 9.1 8.4-9.8 110.2 6.9 6.3-7.5 147.2 4.2 3.9-4.5 80.4 4.9 4.4-5.5 66.8 3.5 3.1-4.0
Thyroid 741.2 24.7 23.9-25.5 209.8 13.9 13.1-14.8 531.4 35.5 34.0-36.9 20.2 0.5 0.4-0.6 8.2 0.5 0.4-0.7 12.0 0.5 0.4-0.6
Hodgkin lymphoma 104.6 3.6 3.3-4.0 58.2 4.1 3.7-4.7 46.4 3.1 2.7-3.6 9.6 0.2 0.2-0.3 6.6 0.4 0.2-0.5 3.0 0.2 0.1-0.3
Non-Hodgkin lymphomas 879.0 24.4 23.6-25.1 469.8 28.6 27.5-29.9 409.2 20.8 19.9-21.8 190.2 4.7 4.4-5.0 104.0 6.1 5.5-6.6 86.2 3.6 3.2-4.0
Myeloma 269.8 7.0 6.6-7.4 152.6 8.8 8.2-9.5 117.2 5.5 5.1-6.0 94.0 2.3 2.1-2.5 52.8 3.0 2.6-3.4 41.2 1.8 1.5-2.0
Leukemias 611.2 17.0 16.4-17.6 351.4 21.5 20.4-22.5 259.8 13.3 12.5-14.1 217.4 5.4 5.1-5.8 117.4 6.8 6.3-7.4 100.0 4.4 4.0-4.9

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.